Ziqi L. Jia

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Author Correction: Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions.

Author Correction: Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions.

Journal: Nature communications

Published: August 25, 2026

ASO Visual Abstract: Analysis of the Current Status of de Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.

ASO Visual Abstract: Analysis of the Current Status of de Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.

Journal: Annals of surgical oncology

Published: December 16, 2025

ASO Author Reflections: Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.

ASO Author Reflections: Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.

Journal: Annals of surgical oncology

Published: October 09, 2025

Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the USA: A Multicenter Real-World Study.

Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the USA: A Multicenter Real-World Study.

Journal: Annals of surgical oncology

Published: June 03, 2025

Advanced strategy for cancer detection based on volatile organic compounds in breath.

Advanced strategy for cancer detection based on volatile organic compounds in breath.

Journal: Journal of nanobiotechnology

Published: March 17, 2025

An Explainable Multimodal Artificial Intelligence Model Integrating Histopathological Microenvironment and EHR Phenotypes for Germline Genetic Testing in Breast Cancer.

An Explainable Multimodal Artificial Intelligence Model Integrating Histopathological Microenvironment and EHR Phenotypes for Germline Genetic Testing in Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 13, 2025

Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance.

Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance.

Journal: Journal of hematology & oncology

Published: December 15, 2024

DNA damage response in breast cancer and its significant role in guiding novel precise therapies.

DNA damage response in breast cancer and its significant role in guiding novel precise therapies.

Journal: Biomarker research

Published: September 05, 2024

Distinct discrepancy in breast cancer organoids recapitulation among molecular subtypes revealed by single-cell transcriptomes analysis.

Distinct discrepancy in breast cancer organoids recapitulation among molecular subtypes revealed by single-cell transcriptomes analysis.

Journal: Clinical and translational medicine

Published: May 16, 2024

Construction and validation of a ubiquitination-related prognostic risk score signature in breast cancer.

Construction and validation of a ubiquitination-related prognostic risk score signature in breast cancer.

Journal: Heliyon

Published: May 10, 2024

Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response.

Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response.

Journal: Genomics, proteomics & bioinformatics

Published: April 08, 2024

Genome sequencing enhances the diagnostic yield and expands the genetic landscape of male breast cancer.

Genome sequencing enhances the diagnostic yield and expands the genetic landscape of male breast cancer.

Journal: Genetics in medicine open

Published: February 09, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026